Fraction non-ablative radiation
Showing 1 - 25 of >10,000
Lung Non-Small Cell Carcinoma, Positive Surgical Margin, Resected Mass Trial in Buffalo (Quality-of-Life Assessment,
Recruiting
- Lung Non-Small Cell Carcinoma
- +9 more
- Quality-of-Life Assessment
- +2 more
-
Buffalo, New YorkRoswell Park Cancer Institute
May 2, 2022
Ventricular Tachycardia, Arrhythmia, Arrhythmic Storm Trial in Montreal (stereotactic body radiotherapy, 20 Gy in 1 fraction)
Enrolling by invitation
- Ventricular Tachycardia
- +3 more
- stereotactic body radiotherapy, 20 Gy in 1 fraction
-
Montreal, Quebec, CanadaCedars Cancer Center, McGill University Health Centre
Jun 1, 2022
Oligometastatic Disease, Oligoprogression, Toxicity Due to Radiotherapy Trial in Canada (Single fraction SABR, Multiple fraction
Not yet recruiting
- Oligometastatic Disease
- +3 more
- Single fraction SABR
- +3 more
-
Kelowna, British Columbia, Canada
- +4 more
Mar 23, 2023
Lung Cancer Trial in Indianapolis (Stereotactic Ablative Body Radiation (SABR))
Terminated
- Lung Cancer
- Stereotactic Ablative Body Radiation (SABR)
-
Indianapolis, Indiana
- +2 more
Jul 22, 2022
Stage III Prostate Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8 Trial (External Beam Radiation Therapy, Stereotactic Body
Not yet recruiting
- Stage III Prostate Cancer AJCC v8
- Stage IVA Prostate Cancer AJCC v8
- External Beam Radiation Therapy
- Stereotactic Body Radiation Therapy
- (no location specified)
Jul 20, 2023
ALK-positive NSCLC Trial in Dallas (Ceritinib, Stereotactic ablative body radiation)
Terminated
- ALK-positive Non-small Cell Lung Cancer
- Ceritinib
- Stereotactic ablative body radiation
-
Dallas, TexasUT Southwestern Medical Center
Jan 31, 2023
Metastatic Carcinoma Trial in Miami, Madison (Stereotactic ablative body radiation therapy)
Recruiting
- Metastatic Carcinoma
- Stereotactic ablative body radiation therapy
-
Miami, Florida
- +1 more
Apr 15, 2022
NSCLC (NSCLC) Trial in Canada, Japan, United States (iSABR, 25 Gray in 1 fraction for small peripheral tumors, iSABR, 50 Gray in
Completed
- Non-small Cell Lung Cancer (NSCLC)
- iSABR, 25 Gray in 1 fraction for small peripheral tumors
- +5 more
-
Stanford, California
- +3 more
Jul 27, 2022
Stage I NSCLC AJCC v7, Stage IA Non-Small Cell Lung Carcinoma AJCC v7, Stage IB Non-Small Cell Lung Carcinoma AJCC v7 Trial in
Recruiting
- Stage I Non-Small Cell Lung Cancer AJCC v7
- +6 more
- Laboratory Biomarker Analysis
- +3 more
-
Buffalo, New YorkRoswell Park Cancer Institute
May 2, 2022
Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in Duarte, New Haven (procedure, drug, radiation, other)
Not yet recruiting
- Lung Non-Small Cell Carcinoma
- Stage IV Lung Cancer AJCC v8
- Biospecimen Collection
- +5 more
-
Duarte, California
- +1 more
Aug 24, 2023
Non Small Cell Lung Cancer Trial in Buffalo (SBRT)
Recruiting
- Non Small Cell Lung Cancer
- SBRT
-
Buffalo, New YorkRoswell Park Cancer Institute
Sep 27, 2022
Resectable Stage IIA to IIIB NSCLC Trial (Nivolumab, (8gy x 3), Platinum Doublet)
Not yet recruiting
- Resectable Stage IIA to IIIB Non-small Cell Lung Cancer
- Nivolumab
- +2 more
- (no location specified)
Aug 10, 2022
Transplant-Related Lung Cancer Trial in Toronto (Radiation: Varying Doses of RT)
Recruiting
- Transplant-Related Lung Cancer
- Radiation: Varying Doses of RT
-
Toronto, Ontario, CanadaToronto General Hospital, University Health Network
Jun 6, 2022
Lung Non-Small Cell Carcinoma, Malignant Solid Tumor, Melanoma Trial in Duarte (procedure, other, radiation)
Not yet recruiting
- Lung Non-Small Cell Carcinoma
- +3 more
- Biospecimen Collection
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Apr 13, 2023
Colorectal Cancer, Liver Metastases Trial in United States (MR Guided Single Fraction Stereotactic Body Radiation Therapy
Recruiting
- Colorectal Cancer
- Liver Metastases
- MR Guided Single Fraction Stereotactic Body Radiation Therapy (SBRT)
-
Basking Ridge, New Jersey
- +6 more
Nov 15, 2023
Recurrent Non-Small Cell Lung Carcinoma, Stage IV NSCLC Trial in Sacramento (Anti-PD-L1 Monoclonal Antibody MPDL3280A,
Terminated
- Recurrent Non-Small Cell Lung Carcinoma
- Stage IV Non-Small Cell Lung Cancer
- Anti-PD-L1 Monoclonal Antibody MPDL3280A
- Stereotactic Body Radiation Therapy
-
Sacramento, CaliforniaUniversity of California Davis
Aug 2, 2022
Radiation Therapy, Bone Metastases, Pain Trial in Winterthur (SBRT)
Active, not recruiting
- Radiation Therapy
- +2 more
- SBRT
-
Winterthur, Kanton Zürich, SwitzerlandKantonsspital Winterthur
Aug 16, 2022
NSCLC (NSCLC) Trial in Duarte, Dallas (Osimertinib, SABR)
Active, not recruiting
- Non-small Cell Lung Cancer (NSCLC)
- Osimertinib
- SABR
-
Duarte, California
- +1 more
May 13, 2022
NSCLC, Renal Cell Carcinoma, Breast Carcinoma Trial (single fraction stereotactic radiosurgery (SSRS), fractionated stereotactic
Not yet recruiting
- NSCLC
- +5 more
- single fraction stereotactic radiosurgery (SSRS)
- fractionated stereotactic radiosurgery (FSRS)
- (no location specified)
Jan 18, 2023
Malignant Lung Tumor, Metastatic Malignant Tumor in the Lung, Non-Small Cell Lung Carcinoma Trial in Palo Alto (device, drug,
Active, not recruiting
- Malignant Lung Neoplasm
- +3 more
- CAPP-Seq
- +2 more
-
Palo Alto, CaliforniaStanford University, School of Medicine
May 31, 2022
Non Small Cell Lung Cancer, Non Small Cell Lung Cancer Metastatic, Non-small Cell Carcinoma Trial in United States (radiation,
Recruiting
- Non Small Cell Lung Cancer
- +4 more
- L-SABR
- +2 more
-
Basking Ridge, New Jersey
- +6 more
Dec 20, 2022
Lung Atypical Carcinoid Tumor, Lung Neuroendocrine Tumor, Lung Non-Small Cell Squamous Carcinoma Trial in Conroe, Houston
Recruiting
- Lung Atypical Carcinoid Tumor
- +13 more
- Nivolumab
- Stereotactic Body Radiation Therapy
-
Conroe, Texas
- +2 more
Feb 25, 2022
Breast Cancer Trial in Milan (Phase I, Phase II)
Recruiting
- Breast Cancer
- Phase I
- Phase II
-
Milan, ItalyIEO, European Institute of Oncology IRCCS
Aug 24, 2021
Stage IA Non-Small Cell Lung Carcinoma, Stage IB Non-Small Cell Lung Carcinoma Trial in Palo Alto (biological, other, radiation)
Completed
- Stage IA Non-Small Cell Lung Carcinoma
- Stage IB Non-Small Cell Lung Carcinoma
- Fresolimumab
- +2 more
-
Palo Alto, CaliforniaStanford University, School of Medicine
Feb 2, 2022